AURAPEP RESEARCH LIBRARY
Compound & Pathway Profiles
Evidence-led profiles of research compounds and the biological pathways studied around them.
20 articles
Compound & Pathway Profiles
KLOW Blend Research: BPC-157, TB-500, GHK-Cu and KPV Component Evidence
What the literature covers for KLOW Blend’s four named components—and why it cannot prove outcomes or synergy for the combined material.
Compound & Pathway Profiles
Glow Blend Research: BPC-157, GHK-Cu and TB-500 Component Evidence
A component-by-component map of the Glow Blend evidence—and why separate studies do not establish the performance or synergy of the finished blend.
Compound & Pathway Profiles
Melanotan I and Melanotan II Research: Related Melanocortin Analogues, Distinct Evidence
Why similarly named melanocortin analogues must not be treated as interchangeable—and what the human evidence actually covers.
Compound & Pathway Profiles
Tesamorelin Research: GHRH-Receptor Signalling and Clinical Evidence Limits
How tesamorelin engages the growth-hormone-releasing-hormone pathway and why approved or trial evidence cannot be generalized beyond the studied material.
Compound & Pathway Profiles
SS-31 Research: Mitochondrial Targeting, Cardiolipin and Evidence Limits
What SS-31, also studied as elamipretide, is designed to target—and why mechanistic and early clinical findings remain material-specific.
Compound & Pathway Profiles
5-Amino-1MQ and NNMT Research: Metabolic Pathways and the Human Evidence Gap
How 5-Amino-1MQ is used to investigate NNMT biology, what mouse studies report and why weight-loss claims exceed the evidence.